3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
7
Uterine Cervical Dysplasia
6
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Squamous Intraepithelial Lesions
1
Precancerous Conditions
1
Papillomavirus Infections
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Acquired Immunodeficiency Syndrome
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
16
Papillomavirus Vaccines
12
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Vaccines
5
Human Papillomavirus DNA Tests
5
Colposcopy
5
Specimen Handling
4
Blood Specimen Collection
4
Watchful Waiting
3
Vaginal Smears
3
Patient Navigation
3
Engerix-B
3
Educational Status
3
fludarabine phosphate
2
fludarabine
2
artesunic acid
2
artemisinin
2
aldesleukin
2
Vaccines, Synthetic
2
Standard of Care
2
Practice Guidelines as Topic
2
Polymerase Chain Reaction
2
Mass Screening
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
GX-188 vaccine
2
Early Intervention, Educational
2
Data Collection
2
Cyclophosphamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Acetic Acid
×
Gynecologic
×
Clear all
NCT07240220
2026-01-15
Merck-4
Indiana University
Phase NA
Not yet recruiting
2,500 enrolled